RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Orbis Medicines

Orbis Medicines

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

Latest funding

$93M Series A ·

Led by NEA · Source: startupintros.com

Total raised: $121M across 2 sourced rounds

All 2 rounds ↓
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Health Care, Medical, Pharmaceutical, Therapeutics.
Stage: Series A.
Based in: Copenhagen, Denmark.
Total raised: $121M in 2 sourced rounds.
Last round: Jan 6, 2025 · 675 days ago.
Headcount: 1–10 employees.
On Recent Funding since: Nov 8, 2026.

Signals

Website registeredSep 9, 2021 (5 years old)

Funding rounds

  1. Series A · $93M
  2. Seed · $28M
  3. Website created

Founders and team

Investors

Companies like Orbis Medicines

Other companies backed by NEA

NEA portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/orbis-medicines (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy